Serum and peritoneal CA-125 levels as diagnostic test for endometriosis
Diagnostic accuracy
OA: closed
CC0
⤵ 26 in-corpus citations
AI-generated summary
This study evaluated serum and peritoneal CA-125 levels as a diagnostic marker for endometriosis in women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To evaluate the clinical utility of CA-125 in the diagnosis of endometriosis and to compare the sensitivity of the serum and the peritoneal test as indicator of disease.
STUDY DESIGN: Peritoneal fluid was obtained at laparoscopy. The quantitative determination of CA-125 in serum and in peritoneal fluid was performed by IRMA-mat CA-125 'two-step method', a two-site immunoradiometric assay, using 35 and 60 U/ml as cutoff.
SETTING: Second Department of Gynecology and Obstetrics, Second University of Naples, Italy.
PARTICIPANTS: A total of 26 women infertile undergoing diagnostic laparoscopy that exhibited endometriosis in 14 patients, normal pelvis in 12 patients (control group).
INTERVENTIONS: None.
RESULTS: CA-125 levels in peritoneal fluid were higher than those found in serum and were significantly elevated (P < 0.05), when compared with the control group, both in women with endometriosis stage I-II and stage III-IV. In serum, CA-125 levels increased only in advanced stage of endometriosis.
CONCLUSIONS: Levels of CA-125 in peritoneal fluid seem to be a more sensitive indicator of disease than serum levels (0.86 vs. 0.36), especially in early stage endometriosis (0.80 vs. 0.20) which tends to be overlooked by the CA-125 serum test.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (25)
- CA 125 in peritoneal fluid and serum of patients with endometriosis via openalex
- CA 125 in peritoneal fluid from patients with endometriosis via openalex
- CA-125 in peritoneal fluid from patients with nonmalignant gynecologic disorders via openalex
- CA-125 levels in endometriosis via openalex
- High CA-125 concentrations in peritoneal fluid of normal cyclic women with various infertility-related factors as demonstrated with two-step immunoradiometric assay via openalex
- W157045796 via openalex
- W2053056059 via openalex
- W2239160715 via openalex
- W2283760758 via openalex
- W2394596183 via openalex
- W2400692327 via openalex
- W2404378598 via openalex
- W2408399589 via openalex
- W2408803737 via openalex
- W2410025583 via openalex
- W2410870346 via openalex
- W2414238171 via openalex
- W2417052106 via openalex
- W6606280675 via openalex
- W6714204224 via openalex
- W6715996686 via openalex
- W42372792 via openalex
- W68155038 via openalex
- W68554369 via openalex
- W73385028 via openalex
Cited by (26)
- <span data-contrast="auto">Evaluating the Prognostic Potential of CA-125 and miRNA Levels in Endometriosis: A Narrative Review <span data-ccp-props="{"> 2024
- Factors that Increase the Likelihood of Ovarian Endometriosis Relapsing after Surgical Excision: A Systematic Review and Meta-Analysis 2023
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- Evaluation of biodegradable microspheres containing nomegestrol acetate in a rat model of endometriosis 2014
- Rapid peptidomic profiling of peritoneal fluid by MALDI-TOF mass spectrometry for the identification of biomarkers of endometriosis 2014
- Diagnostic value of the neutrophil-to-lymphocyte ratio and the combination of serum CA-125 for stages III and IV endometriosis 2013
- Noninvasive diagnosis of moderate to severe endometriosis: the platelet-lymphocyte ratio cannot be a neoadjuvant biomarker for serum cancer antigen 125 2013
- Pathophysiological factors and genetic association in endometriosis 2011
- Avaliação do CA-125 e do CD-23 solúvel em pacientes com endometriose pélvica 2011
- Fourier-transform infrared spectroscopy discriminates a spectral signature of endometriosis independent of inter-individual variation 2011
- Avaliação do CA-125 e do CD-23 solúvel em pacientes com endometriose pélvica 2010
- The clinical significance of Inca serum CA-125 in gynecological diseases 2010
- Serum- und Urinmarker als diagnostische Tests für Endometriose 2010
- Ovarian endometrioma associated with very high serum CA-125 levels 2009
- Ovarian Endometrioma Associated with Very High Serum CA-125 Levels 2009
- Gynecology 2008
- Evaluation of serum CA 125 levels in patients with pelvic pain related to endometriosis 2007
- Diagnostische Tests für Endometriosis 2007
- Evaluation of Serum CA 125 Levels in Patients with Pelvic Pain Related to Endometriosis 2007
- High level of CA 125 due to large endometrioma 2004
- Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report 2004
- Selected Disorders of the Female Reproductive System 2003
- ACOG practice bulletin. Medical management of endometriosis. Number 11, December 1999 (replaces Technical Bulletin Number 184, September 1993). Clinical management guidelines for obstetrician-gynecologists 2000
- Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis 1999
- Expression of aromatase cytochrome P450 in eutopic endometrium and its application as a diagnostic test for endometriosis 1999
- Serum concentrations of soluble human leukocyte class I antigens and of the soluble intercellular adhesion molecule-1 in endometriosis: relationship with stage and non-pigmented peritoneal lesions 1998
Source provenance
- europepmc
- last seen: 2026-10-20T06:13:28.455750+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:59:49.088203+00:00
- unpaywall
- last seen: 2026-10-20T06:27:24.728081+00:00
License: CC0
· commercial use OK